Investors / Canada / Sectoral Asset Management
Sectoral Asset Management
Venture capital · Montreal, QC, Canada · North America
Sectoral Asset Management is an investment advisor focused exclusively on the global healthcare sector, managing public equity and venture capital healthcare strategies for institutions, private banks and family offices. It runs the NEMO late-stage venture funds and the Fonds Medtech Ventures for Canadian medtech, alongside public equity strategies such as Global Healthcare and Emerging Markets Healthcare.
Invests inHealthcare & Biotech
In its own wordshealthcarebiotechmedtechpublic equitieslife sciences
Your fit with Sectoral Asset Management
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsSectoral Asset Management lists 4 checked portfolio companies on its own site and is named in 4 funding rounds, 1 of them as lead. Its most frequent entry is Growth, 100% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 75% of its companies are based in United States. It invests most often alongside U.S. Venture Partners, BNP Paribas Développement and Capricorn Partners.
Counts come from funding rounds that name Sectoral Asset Management, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 0% |
| Growth | 100% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 3 | 1 |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| U.S. Venture Partners | 3 |
| BNP Paribas Développement | 1 |
| Capricorn Partners | 1 |
| Civilization Ventures | 1 |
| Critical Path Ventures | 1 |
| FemHealth Ventures | 1 |
| Forbion | 1 |
| Norwest | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers4100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with U.S. Venture Partners
Compare Sectoral Asset Management head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Sectoral Asset Management| Date | Company | Stage |
|---|---|---|
| 22 Sept 2026 | Series C+ | |
| 16 Sept 2026 | Series C+ | |
| 7 Apr 2026 | Round Led | |
| 20 Aug 2025 | Series C+ |
Round details for Sectoral Asset Management
Amounts, full round histories and every co-investor in Sectoral Asset Management's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
4 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| HighLife Medical develops a transcatheter solution for mitral valve replacement to treat mitral regurgitation | Healthcare & Biotech | Sept 2026Series C+ | Funding round | |
| Iantrek develops and commercializes technologies for micro-interventional ophthalmic surgery, particularly for glaucoma treatment. | Healthcare & Biotech | Aug 2025Series C+ | Funding round | |
| Route 92 Medical develops medical devices for neurovascular intervention. | Healthcare & Biotech | Apr 2026Round | Funding round | |
| Sling Therapeutics develops treatments for thyroid eye disease. | Healthcare & Biotech | Sept 2026Series C+ | Funding round |
About this data
site last read 8 Nov 2026- Site
- sectoral.com
- Last read
- 8 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 20 Aug 2025
- Companies checked
- 4
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Sectoral Asset Management's profile as data
Pull Sectoral Asset Management's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/sectoral.com
# also
GET /v1/firms/sectoral.com/portfolio
GET /v1/firms/sectoral.com/coinvestors
GET /v1/firms/sectoral.com/news